Clinical trials recruiting in Oak Ridge, Tennessee

Phase breakdown

Conditions recruiting in Oak Ridge, Tennessee

Recruiting trials in Oak Ridge, Tennessee

• Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer
  NCT06058377 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Clinical Trial Protocol: Alzheimer's Dementia Underlying Encephalopathy
  NCT07222280 · Phase: Not applicable (e.g. observational or device study) · Ages: 60 Years to 90 Years · Sex: All (male and female)
• Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
  NCT05174169 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
  NCT07037459 · Phase: Phase 3 · Ages: 18 Years to 99 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Oak Ridge, Tennessee?

4 recruiting trials have at least one study site in Oak Ridge, Tennessee.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.